Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1163 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Rank Status Study
21 Completed Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study
Conditions: Cryptosporidiosis;   HIV Infections
Intervention: Drug: Azithromycin
22 Completed Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers
Condition: Human Immunodeficiency Virus
Intervention: Drug: Raltegravir
23 Completed Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Lopinavir/ritonavir;   Drug: HAART;   Drug: Placebo
24 Active, not recruiting A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2838232 PIB (SDD);   Drug: GSK2838232 PIB (API);   Drug: Placebo;   Drug: Ritonavir
25 Completed A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
Conditions: Candidiasis, Oral;   HIV Infections
Interventions: Drug: Clotrimazole;   Drug: Fluconazole
26 Completed
Has Results
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
Conditions: HIV Infection;   HIV;   Acquired Immunodeficiency Syndrome
Interventions: Drug: etravirine (ETR, TMC125);   Drug: efavirenz (EFV)
27 Terminated Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia
Conditions: HIV Infections;   HIV Seronegativity
Intervention: Drug: Tenofovir DF
28 Completed Folinic Acid and Vascular Reactivity in HIV
Condition: Human Immunodeficiency Virus (HIV) Infection
Interventions: Dietary Supplement: Folinic Acid;   Other: Placebo
29 Completed Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: darunavir/ritonavir;   Drug: etravirine;   Drug: Optimized background regimen
30 Completed A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Saquinavir
31 Completed Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Conditions: Neurocognitive Disturbance;   HIV Infection
Interventions: Drug: Lithium;   Drug: Rivastigmine
32 Completed
Has Results
Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants
Conditions: Human Immunodeficiency Virus Type 1 (HIV-1);   HIV Infections
Interventions: Drug: Voriconazole;   Drug: Atazanavir;   Drug: Ritonavir
33 Completed A Study of Azidothymidine in HIV-Infected Children
Conditions: Encephalopathies;   HIV Infections
Interventions: Drug: Zidovudine;   Drug: Didanosine
34 Completed Study of Itraconazole in Patients With Advanced HIV Infection
Condition: HIV Infections
Intervention: Drug: Itraconazole
35 Completed Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)
Condition: HIV Infection
Interventions: Drug: efavirenz;   Drug: didanosine;   Drug: lamivudine
36 Completed A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine;   Drug: Aldesleukin
37 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
38 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
39 Completed Effect of Atazanavir on Endothelial Function in HIV-Infected Patients
Conditions: HIV Infections;   Dyslipidemia
Intervention: Drug: ATAZANAVIR
40 Completed A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy
Conditions: Acquired Immunodeficiency Syndrome;   Anemia
Intervention: Drug: epoetin alfa

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years